Hepatic neuromodulation to treat fatty liver conditions

1. A method of treating conditions associated with a fatty liver or symptoms associated with a fatty liver, the method comprising:

positioning a distal portion of an energy delivery device within a common hepatic artery of a subject,

wherein the energy delivery device comprises one or more electrodes positioned at the distal portion of the energy delivery device;

denervating a sympathetic nerve using the energy delivery device by intravascularly delivering energy to an inner wall of the common hepatic artery at a target location sufficient to treat a fatty liver condition,

wherein the energy delivered by the energy delivery device comprises radiofrequency (RF) energy delivered by the one or more electrodes; and

removing the energy delivery device from the subject.

2. The method of claim 1 , wherein the fatty liver condition is non-alcoholic steatohepatitis (NASH).

3. The method of claim 1 , wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).

4. The method of claim 1 , further comprising confirming denervation of the sympathetic nerve.

5. The method of claim 1 , wherein the distal portion of the energy delivery device comprises an expandable structure configured to facilitate contact with the inner wall of the common hepatic artery, and wherein the expandable structure is selected from the group consisting of: a scaffold, a coil, a balloon, and a spring.

6. The method of claim 1 , wherein the distal portion of the energy delivery device is configured to maintain contact with the inner wall at a contact pressure of between 0.1 g/mm 2 and 10 g/mm 2 .

7. The method of claim 1 ,

wherein the RF energy is delivered at a frequency in the range of 50 kHz to 5 MHz,

wherein the RF energy is delivered to heat the sympathetic nerve to a temperature sufficient to cause ablation of the sympathetic nerve,

wherein the sympathetic nerve is a nerve of the hepatic plexus, and

wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).

8. A method of treating conditions associated with a fatty liver or symptoms associated with a fatty liver, the method comprising:

positioning a distal end of a neuromodulation device within a hepatic artery segment of a subject;

modulating one or more nerves that innervate a liver using the neuromodulation device sufficient to treat a fatty liver condition; and

removing the neuromodulation device from the subject,

wherein at least a portion of the distal end of the neuromodulation device is configured to contact a wall of the hepatic artery segment at a target location while the one or more nerves are being modulated.

9. The method of claim 8 , wherein modulating the one or more nerves comprises denervating one or more sympathetic nerves of a hepatic plexus.

10. The method of claim 8 , wherein the fatty liver condition is non-alcoholic steatohepatitis (NASH).

11. The method of claim 8 , wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).

12. The method of claim 8 ,

wherein the neuromodulation device comprises a radiofrequency (RF) energy delivery catheter comprising one or more electrodes at a distal section of the RF energy delivery catheter configured to contact the wall of the hepatic artery segment while the one or more nerves are being modulated,

wherein the one or more electrodes are configured to deliver RF energy at a frequency in the range of 50 kHz to 5 MHz,

wherein the RF energy is delivered to heat the one or more nerves to a temperature sufficient to cause ablation of the one or more nerves,

wherein the one or more nerves are sympathetic nerves of a hepatic plexus, and

wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).

13. The method of claim 9 , further comprising confirming said denervating of the one or more nerves.

14. The method of claim 8 , wherein the hepatic artery segment is a common hepatic artery or a proper hepatic artery.

15. The method of claim 8 , wherein the neuromodulation device comprises an ablation catheter configured to deliver energy sufficient to ablate the one or more nerves.

16. The method of claim 8 , wherein the neuromodulation device comprises a delivery catheter configured to deliver fluid sufficient to modulate the one or more nerves.

17. A method of treating conditions associated with a fatty liver or symptoms associated with a fatty liver, the method comprising:

providing an energy delivery device configured for:

accessing a portion of vasculature in the vicinity of a hepatic plexus of a subject; and

delivering energy through a wall of the vasculature sufficient to modulate one or more nerves of the hepatic plexus,

wherein modulation of the one or more nerves is sufficient to treat a fatty liver condition.

18. The method of claim 17 ,

wherein the energy delivery device is configured to deliver at least one of microwave, thermal, electrical, ultrasonic, and laser energy.

19. The method of claim 17 ,

wherein the energy delivery device is a radiofrequency (RF) energy delivery catheter comprising one or more electrodes at a distal end of the RF energy delivery catheter configured to contact the wall of the vasculature while the one or more nerves are being modulated, wherein the one or more electrodes are configured to deliver RF energy at a frequency in the range of 50 kHz to 5 MHz,

wherein the RF energy is delivered to heat the one or more nerves to a temperature sufficient to cause ablation of the one or more nerves,

wherein the one or more nerves are sympathetic nerves, and

wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).

20. The method of claim 17 ,

wherein the energy has a frequency in the range of 3 kHz to 300 GHz,

wherein said modulation comprises ablation of the one or more nerves, and wherein the fatty liver condition is non-alcoholic fatty liver disease (NAFLD).